關於「Rexulti indication」標籤，搜尋引擎有相關的訊息討論：

REXULTI® (brexpiprazole) | For Healthcare Professionals。

INDICATIONS. REXULTI is indicated for: Use as an adjunctive therapy to antidepressants in adults with major depressive disorder; Treatment of schizophrenia ...： 。

Rexulti (Brexpiprazole Tablets): Uses, Dosage, Side Effects ... - RxList。

Rexulti (Brexpiprazole Tablets) may treat, side effects, dosage, ... In such patients, consider discontinuation of REXULTI at the first sign of a clinically ...： 。

Rexulti oral: Uses, Side Effects, Interactions, Pictures ... - WebMD。

Find patient medical information for Rexulti oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.： 。

Brexpiprazole: MedlinePlus Drug Information。

Brexpiprazole is not approved by the Food and Drug Administration (FDA) for the treatment of behavior disorders in older adults with dementia. Talk to the ...。

Rexulti: Uses, Side Effects & Warnings - Drugs.com。

2020年3月2日 · Rexulti (brexpiprazole) is a serotonin-dopamine activity modulator (SDAM) used for ... and use Rexulti only for the indication prescribed.： 。

Brexpiprazole (Rexulti) - NCBI。

INDICATIONS AND DOSAGE ... Brexpiprazole is FDA-approved for the treatment of schizophrenia with dose initiation starting at 1 mg once daily and titration to a ...： 。

What is the role of SDAMs in the treatment of major depressive ...。

2019年10月7日 · SDAMs include brexpiprazole (Rexulti) and aripiprazole (Abilify). SDAMs act as a partial agonist at 5-HT1A and dopamine D2 receptors at ...。

[PDF] Reference ID: 4219848 - Accessdata.fda.gov。

Administer REXULTI once daily with or without food (2.1, 2.2, 12.3). Indication. Starting Dose. Recommended. Dose. Maximum Dose. MDD (2.1). 0.5 mg/day or.： 。

[PDF] Care Choices (for HSA Plans) Medication Guide - September 2021。

If an indicator is present in the column, the medication may be available only ... REXULTI - brexpiprazole tab 0.5 mg 6 ... MEIJER ESSENTIAL BLOOD GL -.。

Low-Dose Tramadol as an Off-Label Antidepressant: A Data Mining ...。

2020年10月29日 · 30, Rexulti, 73, 6.8 ... response by three of the authors(93) noted that “...these findings may be susceptible to confounding by indication, ...